Search Results
124 items found for "fibrotic bone disease"
- Ep 102 with Dr Caron Tribute Part 3
neurotransmitters and how they might underlie brain and behavior disorders such as schizophrenia, Parkinson's disease
- Stable Binding of Full-Length Chemerin is Driven by Negative Charges in the CMKLR1 N-terminus
This may help to develop more potent ligands for the treatment of inflammatory related diseases."
- Ep 148 with Dr Arthur Christopoulos
, molecular and cellular pharmacology, medicinal chemistry, and preclinical models of behaviour and disease work has been applied to studies encompassing neurological and psychiatric disorders, cardiovascular disease Lastly, they discussed the progress of new drugs targeting specific receptors for various diseases, with
- Ep 149 with Dr Arthur Christopoulos
, molecular and cellular pharmacology, medicinal chemistry, and preclinical models of behaviour and disease work has been applied to studies encompassing neurological and psychiatric disorders, cardiovascular disease Lastly, they discussed the progress of new drugs targeting specific receptors for various diseases, with
- A GPCR-neuropeptide axis dampens hyperactive neutrophils by promoting an alternative-like polarization during bacterial infection
expressed NPFF, these findings could have broad implications in various infectious and inflammatory diseases
- GPCR Retreat 2023 - Part I
laboratory has gained valuable insights into the genetic basis and pathophysiology of lymphatic vascular disease , preeclampsia and sex-dependent cardiovascular disease.
- Atypical Structure and Function of Typical Chemokine Receptors
Our laboratory is working to help patients by developing genetically-modified mice that have disease-causing
- Small-molecule targeting of GPCR-independent noncanonical G-protein signaling in cancer
small molecules can selectively disable noncanonical mechanisms of G-protein activation dysregulated in disease
- Interaction with the cell adhesion molecule NEGR1 affects mGluR5 cell signalling
were shown to be very effective to rescue the cell death observed in a mouse model of Huntington’s disease
- Structural Basis for the Recognition of GPRC5D by Talquetamab, a Bispecific Antibody for Multiple Myeloma
Despite advances in the treatment, many patients experience disease relapse or become refractory to treatment
- In Silico Design of Novel RGS2-Galpha-q Interaction Inhibitors with Anticancer Activity
essential in regulating GPCR signaling, and most members are implicated as critical nodes in human diseases
- GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis
Exosomes transport a variety of macromolecules and modulate intercellular communication in physiology and disease
- Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling
Conclusions: Antagonizing the NPYRs has been implicated as a treatment for a wide variety of diseases
- Ep 132 with Dr. Richard Premont
where he remained until 2018 studying GPCRs and their signaling pathways in the liver and in liver disease
- Ep 130 with Dr. Richard Premont
where he remained until 2018 studying GPCRs and their signaling pathways in the liver and in liver disease
- Agonists of galanin subtype 2 receptor may prevent pancreatic cancer and agonists of angiotensin II type 2 receptor may prevent colorectal cancer
cancer Published date June 24, 2024 Abstract "Pancreatic ductal adenocarcinoma (PDAC) remains a dreadful disease
- C5aR2 receptor: The genomic twin of the flamboyant C5aR1
the C5aR1, which has received enormous attention for its role in both acute and chronic inflammatory diseases
- Ep 133 with Dr. Richard Premont
where he remained until 2018 studying GPCRs and their signaling pathways in the liver and in liver disease
- Ep 42 with Dr. Randy Hall
Randy’s lab has a special interest in studying disease-associated mutations to human GPCRs that perturb
- Ep 131 with Dr. Richard Premont
where he remained until 2018 studying GPCRs and their signaling pathways in the liver and in liver disease
- Session VI | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Initial impairment of synaptic functions, which occurs early in Alzheimer’s disease, and subsequent massive My research focus is the mechanisms of neural circuit development, function and disease."
- CaaX-motif-adjacent residues influence G protein gamma (Gγ) prenylation under suboptimal conditions
prenylation contributes to multiple disorders, including cancers and vascular and neurodegenerative diseases
- The combination of brentuximab vedotin and chidamide synergistically suppresses the proliferation of T-cell lymphoma cells through the enhancement of apoptosis
Published date November 3, 2023 Abstract " Purpose: Peripheral T-cell lymphoma (PTCL) is an aggressive disease
- Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted Therapy
Published date November 1, 2022 Abstract Pancreatic ductal adenocarcinoma (PDAC) remains an aggressive disease
- Deciphering a GPCR-lncRNA-miRNA Nexus: Identification of an Aberrant Therapeutic Target in Ovarian Cancer
primarily due to the lack of early diagnostic tools, effective targeted therapy, and clear understanding of disease
- GPR97 depletion aggravates imiquimod-induced psoriasis pathogenesis via amplifying IL-23/IL-17 axis signal pathway
indicated that beclomethasone dipropionate (BDP), an agonist of GPR97, attenuated the psoriasis-like skin disease
- Ep 47 with Dr Simone Promel Dr Ines Liebscher
there was not much known other than that they are huge and somehow play important roles in health and disease
- Molecular characterization of breast cancer cell pools with normal or reduced ability to respond to progesterone: a study based on RNA-seq
Patients with ERα-positive/PR-negative tumors have shorter disease-free and overall survival than patients